The below guidelines / recommendations / publications advising LIC measurent is used on the diagnosis and management of patient with (suspected) hereditary haemochromatosis.
Zoller, H., et al., EASL Clinical Practice Guidelines on haemochromatosis. J Hepatol, 2022. 77(2): p. 479-502.
https://pubmed.ncbi.nlm.nih.gov/35662478
Girelli, D., et al., Hemochromatosis classification: update and recommendations by the BIOIRON Society. Blood, 2022. 139(20): p. 3018-3029.
https://pubmed.ncbi.nlm.nih.gov/34601591
Fitzsimons, E.J., et al., Diagnosis and therapy of genetic haemochromatosis (review and 2017 update). British Journal of Haematology, 2018. 181(3): p. 293-303.
https://pubmed.ncbi.nlm.nih.gov/29663319
Kowdley, K.V., et al., ACG Clinical Guideline: Hereditary Hemochromatosis. Am J Gastroenterol, 2019. 114(8): p. 1202-1218.
https://pubmed.ncbi.nlm.nih.gov/31335359
Henninger, B., et al., Practical guide to quantification of hepatic iron with MRI. European Radiology, 2019.
https://pubmed.ncbi.nlm.nih.gov/31392478
Franca, M. and J.G. Carvalho, MR imaging assessment and quantification of liver iron. Abdom Radiol (NY), 2020. 45(11): p. 3400-3412.
https://pubmed.ncbi.nlm.nih.gov/32435848
Kowdley, K.V., et al., Utility of hepatic iron index in American patients with hereditary hemochromatosis: A multicenter study. Gastroenterology, 1997. 113(4): p. 1270-1277.